We were excited to be hosting Tribe Public's Webinar Presentation and Q&A Event that was held Thursday, November 17, 2022.
Eric A. Adams, CEO & Eric C. Hsu, PhD, Senior Vice President, Pre-Clinical Research & Development of InMed Pharmaceuticals (NASDAQ: INM) delivered a presentation titled "Exploring The Neuroprotective Qualities of Rare Cannabinoids" & addressed a Q&A session at the end of the presentation.
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet medical needs. They also have significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors.
View Disclaimer: https://tribepublic.com/disclaimers.
0 Comments